Advanced Search

Technical Analysis for CPRX - Catalyst Pharmaceutical Partners, Inc.

Grade Last Price % Change Price Change
C 4.38 2.10% 0.09
CPRX closed up 2.1 percent on Tuesday, April 13, 2021, on 52 percent of normal volume.
9 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical CPRX trend table...
Date Alert Name Type % Chg
Hammer Candlestick Bullish 2.10%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.10%
NR7 Range Contraction 2.10%
NR7-2 Range Contraction 2.10%
Fell Below 20 DMA Bearish 1.15%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.15%
NR7 Range Contraction 1.15%
NR7-2 Range Contraction 1.15%
MACD Bearish Signal Line Cross Bearish -1.13%
20 DMA Support Bullish -1.13%
Older End-of-Day Signals for CPRX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 18 hours ago
Non-ADX 1,2,3,4 Pullback Entry about 23 hours ago
Hammer Candlestick Entry about 23 hours ago
Rose Above Previous Day's High about 23 hours ago
Up 2% about 23 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators Basic chart:

Profile

Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. It focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders. The company's principal product includes Firdapse that is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome. It also develops CPP-115, a GABA aminotransferase inhibitor for the treatment of epilepsy and other selected central nervous disease indications; and CPP-109 for the treatment of Tourette Syndrome. Catalyst Pharmaceutical Partners, Inc. has strategic collaboration agreement with BioMarin. The company was founded in 2002 and is based in Coral Gables, Florida.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Pharmaceutical Industry Health Sciences Medication Virotherapy Disorders Prescription Drug Epilepsy Pharmaceutical Sciences Stage Specialty Pharmaceutical Prescription Drugs Coral Gables Myasthenia Pharmaceutical Partners Urological Diseases Biomarin Pharmaceutical Lambert Eaton Myasthenic Lambert Eaton Myasthenic Syndrome Treatment Of Epilepsy

Is CPRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Apr 5 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stock Catapults 28% Though Its Price And Business Still Lag The Market
Mar 22 Catalyst Pharmaceuticals authorizes $40M share repurchase program; shares rise
Mar 22 Catalyst Pharmaceuticals Announces $40 Million Share Repurchase Program
Mar 21 With EPS Growth And More, Catalyst Pharmaceuticals (NASDAQ:CPRX) Is Interesting
Mar 17 Catalyst Pharmaceuticals Inc.: Attractive Value Supported By New Growth Opportunities
Mar 16 Catalyst Pharmaceuticals, Inc. (CPRX) CEO Patrick McEnany on Q4 2020 Results - Earnings Call Transcript
Mar 16 Catalyst Pharma 4Q Revenue, Earnings Outperform Estimates
Mar 16 Catalyst Pharmaceuticals, Inc. to Host Earnings Call
Mar 15 Catalyst Pharmaceutical (CPRX) Beats Q4 Earnings and Revenue Estimates
Mar 15 Catalyst Pharmaceuticals EPS beats by $0.02, beats on revenue
See more CPRX news...

Indicators

Indicator Value
52 Week High 5.19
52 Week Low 2.88
Average Volume 1,734,361
200-Day Moving Average 3.78
50-Day Moving Average 4.20
20-Day Moving Average 4.41
10-Day Moving Average 4.45
Average True Range 0.22
ADX 20.31
+DI 24.37
-DI 20.29
Chandelier Exit (Long, 3 ATRs ) 4.38
Chandelier Exit (Short, 3 ATRs ) 4.39
Upper Bollinger Band 4.74
Lower Bollinger Band 4.08
Percent B (%b) 0.46
BandWidth 14.81
MACD Line 0.09
MACD Signal Line 0.12
MACD Histogram -0.0276
Fundamentals Value
Market Cap 453.98 Million
Num Shares 104 Million
EPS 0.67
Price-to-Earnings (P/E) Ratio 6.54
Price-to-Sales 3.27
Price-to-Book 2.40
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.61
Resistance 3 (R3) 4.60 4.50 4.57
Resistance 2 (R2) 4.50 4.44 4.51 4.56
Resistance 1 (R1) 4.44 4.40 4.47 4.46 4.55
Pivot Point 4.35 4.35 4.36 4.35 4.35
Support 1 (S1) 4.29 4.29 4.32 4.30 4.21
Support 2 (S2) 4.19 4.25 4.20 4.20
Support 3 (S3) 4.13 4.19 4.19
Support 4 (S4) 4.15